DEC 13, 2017 03:03 PM PST
Nanoparticles May Be the Future of Cancer Screening
WRITTEN BY: Xuan Pham
3 5 341

Image credit: Pixabay.com

Despite advances in cancer medicine, we are limited by what we can detect. That is, doctors can’t treat something that they can’t see. And in many cases, by the time the cancer is detectable, the disease becomes harder to treat. Now researchers at Rutgers University say a nanoprobe could give doctors the rare window of opportunity to treat the cancer even before it has been detected by conventional diagnostic methods.

The prognosis of many cancer largely depends on when the cancer is caught. The earlier the diagnosis, the better the odds for the patient. By contrast, cancers detected at the late stages generally have worse outcomes. In fact, about 90% of cancer deaths are attributed to metastatic events.

While they’re improving, the current available methods for cancer detection (scans, X-rays, biopsies) are not always accurate when the cancer is in its earliest stages. But it is exactly this early stage that the research team targeted, as it would arguably give patients the best odds.

The team developed nanoparticles that emit short-wave infrared light when encountering metastatic lesions. This nanoprobe is injected intravenously, and is designed to track cancer metastasis at the smallest level. The team called these small cancerous lesions “microlesions.”

In a mouse model of human breast cancer, the nanoprobes picked up microlesions in the bones and the adrenal glands of the animal. By contrast, the same microlesions were undetected until later with standard magenetic resonance imaging (MRI) techniques.

“We've always had this dream that we can track the progression of cancer in real time, and that's what we've done here. We've tracked the disease in its very incipient stages," said Dr. PrabhasMoghe.

"Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go," explained Dr. Vidya Ganapathy, the study’s co-author. "You can treat the tumors intelligently because now you know the address of the cancer."

The team asserted the nanoprobes can detect over 100 different types of cancer. Furthermore, they estimate the nanotechnology may be ready for the clinic in about 5 years.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 08, 2018
Genetics & Genomics
APR 08, 2018
Free Tool Identifies Rare Cancer Mutations Accurately
Researchers can now use open-source software to identify rare genetic mutations in cancer cells with greater accuracy than existing techniques.
APR 14, 2018
Immunology
APR 14, 2018
A Vaccine for When Cancer Forms from Human Retroviruses
A vaccine to prevent leukemia and other diseases of the immune system caused by a specific viral infection is now a very real idea. A new study from Kyoto
APR 24, 2018
Clinical & Molecular DX
APR 24, 2018
An Atlas of the Human Genome
Scientists from the Hebrew University of Jerusalem want to identify individual genes responsible for specific diseases. This goal inspired their new Nature
MAY 23, 2018
Clinical & Molecular DX
MAY 23, 2018
Rapidly Screening Genes in 'Living Test Tubes'
Diagnosing rare disorders is often extremely challenging. Now scientists have developed a new tool for that purpose.
JUN 12, 2018
Cell & Molecular Biology
JUN 12, 2018
Loss of Brain Lesions may Indicate Worsening MS
New research could help doctors determine how severe a case of multiple sclerosis will become.
JUL 01, 2018
Videos
JUL 01, 2018
Growing Patient Cells on a Chip for Personalized Drug Screens
This work could help eliminate animal models, and tailor medicine to the patient.
Loading Comments...